Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer
Interventions: COMBINATION_PRODUCT: neoadjuvant chemotherapy
Sponsor: Zhejiang Cancer Hospital